"A world rated African organisation dedicated to helping eradicate HIV and TB - a global authority."

During the past decade, CAPRISA- The Aurum Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CAPRISA- The Aurum Institute" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials as a collaborator, "European and Developing Countries Clinical Trials Partnership (EDCTP)" with 2 trials as a collaborator, "German Federal Ministry of Education and Research" with 2 trials as a collaborator, "Johns Hopkins University" with 2 trials as a collaborator and "London School of Hygiene and Tropical Medicine" with 2 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "CAPRISA- The Aurum Institute" are "HIV" (2 trials), "HIV Infections" (1 trials), "Other Specified Pulmonary Tuberculosis" (1 trials), "Pregnancy Related" (1 trials) and "Pulmonary Tuberculosis" (1 trials). Many other conditions were trialed in "CAPRISA- The Aurum Institute" in a lesser frequency.

Most popular intervention types in "CAPRISA- The Aurum Institute" are "Drug" (3 trials), "Behavioral" (1 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bedaquiline, Delamanid, Moxifloxacin" (1 trials), "Care Facilitation" (1 trials), "Isoniazid" (1 trials), "Midazolam oral solution" (1 trials) and "Moxifloxacin" (1 trials). Other intervention names were less common.

The vast majority of trials in "CAPRISA- The Aurum Institute" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "CAPRISA- The Aurum Institute". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in CAPRISA- The Aurum Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CAPRISA- The Aurum Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".